Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXQG0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,129
Award facts
- Contract value 100% obligated
- $11,128.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,128.95 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on December 12, 2025, with completion expected by December 15, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This award reflects AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical supply chain, specifically supporting military and veteran healthcare systems. XELJANZ XR is a brand-name immunosuppressive medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company was competitively selected through open competition, demonstrating its capability to meet federal procurement standards for pharmaceutical distribution and medical supply delivery.
Quick answers
Who was awarded contract SPE2DR26FXQG0?
SPE2DR26FXQG0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FXQG0 worth?
The government has obligated $11,129 on SPE2DR26FXQG0.
Is contract SPE2DR26FXQG0 an order under another contract?
Yes. SPE2DR26FXQG0 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXQG0 competed?
The extent of competition for SPE2DR26FXQG0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award